A Senate report has given a peek into the rot at Kenya Medical Supplies Authority (Kemsa) that allowed companies to profiteer from the pandemic even as Members of Parliament protested the transfer of the board chair.
The Senate’s Committee on Health released a report of their eight-month-long inquiry into Kenya’s drug supplier, uncovering massive schemes that allowed companies to profiteer from the pandemic.